About

Reto Jost is Innovation and Business Development Director with Ypsomed Delivery Systems.

He has been with Ypsomed since 2014 in a number of roles in product management and business development, working with pharma companies to develop and bring to market innovative self-injection systems. Since 2018, his main focus has been on new product innovation, with particular focus on large-volume injections.

Mr Jost holds an MSc in Mechanical Engineering from ETH Zurich, Switzerland, and a CAS in Business Administration from HES-SO, Fribourg, Switzerland. He has broad experience in medical devices, having worked in the industry since 2006.

Contributions

INJECTION

THE NEW YPSOMATE™ 5.5 – TAKING HANDHELD SELF-INJECTION BEYOND VOLUMES OF 2 ML

Reto Jost introduces YpsoMate 5.5, the staked-needle-syringe-based, two-step autoinjector for injection volumes in the 2.0–5.5 mL range, and discusses the drivers of the demand for high-volume, high-rate subcutaneous drug delivery using handheld autoinjectors.

More contributions

WEARABLES

SIMPLIFYING LARGE-VOLUME PATCH INJECTION FOR PHARMA AND PATIENTS

Reto Jost provides an update on the YpsoDose platform and its importance as the driver for the business unit’s new patch injector franchise.